Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1Lymphoid 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 12Small Cell Lung Carcinoma 4Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 2Neuroendocrine Tumors 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Mesothelioma 2Thymoma 1Somatostatinoma 1Recurrence 1Pheochromocytoma 1Ovarian Neoplasms 1Multiple Myeloma 1Melanoma 1Insulinoma 1Hereditary Sensory and Autonomic Neuropathies 1Glucagonoma 1Gastrointestinal Neoplasms 1Gastrinoma 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Large Cell 1Carcinoma, Islet Cell 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

sotorasib 1pembrolizumab 1lorlatinib 1liposomal doxorubicin 1encorafenib 1cemiplimab 1binimetinib 1berzosertib 1Topotecan 1Taxes 1Paclitaxel 1PX-866 1NVP-BKM120 1Lomustine 1Irinotecan 1Gemcitabine 1Everolimus 1Doxorubicin 1Docetaxel 1Cetuximab 1Carboplatin 1Albumin-Bound Paclitaxel 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Everolimus × Thoracic × Clear all
NCT01470209 2018-03-19

A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

Emory University

Phase 1 Completed
43 enrolled
Thoracic

Lung Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡